Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

VMD vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VMD
Viemed Healthcare, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$353M
5Y Perf.+10.6%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%

VMD vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VMD logoVMD
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$353M$161.07B
Revenue (TTM)$287M$10.58B
Net Income (TTM)$15M$2.98B
Gross Margin57.5%66.3%
Operating Margin8.2%30.5%
Forward P/E19.2x43.8x
Total Debt$16M$303M
Cash & Equiv.$14M$3.37B

VMD vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VMD
ISRG
StockMay 20May 26Return
Viemed Healthcare, … (VMD)100110.6+10.6%
Intuitive Surgical,… (ISRG)100234.6+134.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: VMD vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VMD leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Intuitive Surgical, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
VMD
Viemed Healthcare, Inc.
The Income Pick

VMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 0.95
  • Rev growth 20.5%, EPS growth 32.1%, 3Y rev CAGR 24.9%
  • Lower volatility, beta 0.95, Low D/E 11.1%, current ratio 1.18x
Best for: income & stability and growth exposure
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG is the clearest fit if your priority is long-term compounding.

  • 5.5% 10Y total return vs VMD's 413.5%
  • 28.2% margin vs VMD's 5.2%
  • 14.8% ROA vs VMD's 7.5%, ROIC 15.0% vs 11.6%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthVMD logoVMD20.5% revenue growth vs ISRG's 20.5%
ValueVMD logoVMDLower P/E (19.2x vs 43.8x)
Quality / MarginsISRG logoISRG28.2% margin vs VMD's 5.2%
Stability / SafetyVMD logoVMDBeta 0.95 vs ISRG's 1.02
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)VMD logoVMD+26.7% vs ISRG's -15.4%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs VMD's 7.5%, ROIC 15.0% vs 11.6%

VMD vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VMDViemed Healthcare, Inc.
FY 2025
Equipment Sales
66.9%$50M
Service
33.1%$25M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

VMD vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGVMD

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 5 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 36.9x VMD's $287M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to VMD's 5.2%. On growth, VMD holds the edge at +27.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$287M$10.6B
EBITDAEarnings before interest/tax$46M$3.8B
Net IncomeAfter-tax profit$15M$3.0B
Free Cash FlowCash after capex$26M$2.8B
Gross MarginGross profit ÷ Revenue+57.5%+66.3%
Operating MarginEBIT ÷ Revenue+8.2%+30.5%
Net MarginNet income ÷ Revenue+5.2%+28.2%
FCF MarginFCF ÷ Revenue+9.0%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+27.5%+23.0%
EPS Growth (YoY)Latest quarter vs prior year0.0%+18.8%
ISRG leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

VMD leads this category, winning 6 of 6 comparable metrics.

At 24.9x trailing earnings, VMD trades at a 57% valuation discount to ISRG's 57.6x P/E. On an enterprise value basis, VMD's 7.2x EV/EBITDA is more attractive than ISRG's 43.6x.

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
Market CapShares × price$353M$161.1B
Enterprise ValueMkt cap + debt − cash$356M$158.0B
Trailing P/EPrice ÷ TTM EPS24.89x57.62x
Forward P/EPrice ÷ next-FY EPS est.19.19x43.84x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple7.21x43.62x
Price / SalesMarket cap ÷ Revenue1.31x16.00x
Price / BookPrice ÷ Book value/share2.62x9.17x
Price / FCFMarket cap ÷ FCF29.59x64.67x
VMD leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 8 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $11 for VMD. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to VMD's 0.11x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs VMD's 4/9, reflecting solid financial health.

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+10.5%+16.9%
ROA (TTM)Return on assets+7.5%+14.8%
ROICReturn on invested capital+11.6%+15.0%
ROCEReturn on capital employed+13.2%+16.5%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.11x0.02x
Net DebtTotal debt minus cash$2M-$3.1B
Cash & Equiv.Liquid assets$14M$3.4B
Total DebtShort + long-term debt$16M$303M
Interest CoverageEBIT ÷ Interest expense14.61x
ISRG leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $9,624 for VMD. Over the past 12 months, VMD leads with a +26.7% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs VMD's -5.1% — a key indicator of consistent wealth creation.

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date+27.6%-19.3%
1-Year ReturnPast 12 months+26.7%-15.4%
3-Year ReturnCumulative with dividends-14.6%+49.6%
5-Year ReturnCumulative with dividends-3.8%+58.7%
10-Year ReturnCumulative with dividends+413.5%+554.2%
CAGR (3Y)Annualised 3-year return-5.1%+14.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

VMD leads this category, winning 2 of 2 comparable metrics.

VMD is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than ISRG's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VMD currently trades 90.5% from its 52-week high vs ISRG's 75.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5000.95x1.02x
52-Week HighHighest price in past year$10.18$603.88
52-Week LowLowest price in past year$5.93$427.84
% of 52W HighCurrent price vs 52-week peak+90.5%+75.1%
RSI (14)Momentum oscillator 0–10034.742.4
Avg Volume (50D)Average daily shares traded312K1.8M
VMD leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates VMD as "Buy" and ISRG as "Buy".

MetricVMD logoVMDViemed Healthcare…ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60
# AnalystsCovering analysts155
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.7%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VMD leads in 2 (Valuation Metrics, Risk & Volatility).

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

VMD vs ISRG: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is VMD or ISRG a better buy right now?

For growth investors, Viemed Healthcare, Inc.

(VMD) is the stronger pick with 20. 5% revenue growth year-over-year, versus 20. 5% for Intuitive Surgical, Inc. (ISRG). Viemed Healthcare, Inc. (VMD) offers the better valuation at 24. 9x trailing P/E (19. 2x forward), making it the more compelling value choice. Analysts rate Viemed Healthcare, Inc. (VMD) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VMD or ISRG?

On trailing P/E, Viemed Healthcare, Inc.

(VMD) is the cheapest at 24. 9x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Viemed Healthcare, Inc. is actually cheaper at 19. 2x.

03

Which is the better long-term investment — VMD or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -3. 8% for Viemed Healthcare, Inc. (VMD). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus VMD's +413. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VMD or ISRG?

By beta (market sensitivity over 5 years), Viemed Healthcare, Inc.

(VMD) is the lower-risk stock at 0. 95β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 7% more volatile than VMD relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 11% for Viemed Healthcare, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VMD or ISRG?

By revenue growth (latest reported year), Viemed Healthcare, Inc.

(VMD) is pulling ahead at 20. 5% versus 20. 5% for Intuitive Surgical, Inc. (ISRG). On earnings-per-share growth, the picture is similar: Viemed Healthcare, Inc. grew EPS 32. 1% year-over-year, compared to 22. 6% for Intuitive Surgical, Inc.. Over a 3-year CAGR, VMD leads at 24. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VMD or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 5. 5% for Viemed Healthcare, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 7. 7% for VMD. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VMD or ISRG more undervalued right now?

On forward earnings alone, Viemed Healthcare, Inc.

(VMD) trades at 19. 2x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 24. 7x cheaper on a one-year earnings basis.

08

Which pays a better dividend — VMD or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is VMD or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). Both have compounded well over 10 years (ISRG: +554. 2%, VMD: +413. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VMD and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

VMD

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 5%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VMD and ISRG on the metrics below

Revenue Growth>
%
(VMD: 27.5% · ISRG: 23.0%)
Net Margin>
%
(VMD: 5.2% · ISRG: 28.2%)
P/E Ratio<
x
(VMD: 24.9x · ISRG: 57.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.